Injectable Therapy Is ‘Magic’ for Those Who Can’t Take HIV Pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found.

University of California San Francisco
Give to UCSFPatients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found.
A Q&A w/Alison Cohen, PhD, MPH, who is among the estimated 5% of the population with Long COVID. She talks through the implications of Long COVID, and how she applies her scientific and personal experience to research this debilitating condition.
A new UCSF study shows that the human lungs have just as many blood-producing stem cells as bone marrow. These stem cells are a precious resource for a variety of therapies for conditions like leukemia or lung diseases.
Brian T. Feeley, MD, FAOSS, UCSF orthopaedic surgeon and researcher, has been awarded the 2025 Kappa Delta Elizabeth Winston Lanier Award by American Academy of Orthopaedic Surgeons (AAOS). He was
UCSF Health has opened the Peninsula Outpatient Center in downtown Burlingame to bring the health system’s world-class specialty and cancer care close to home with a fifth location on the Peninsula.
UCSF study finds that less than half of homeless individuals regularly use illicit drugs, with methamphetamines being more common than opioids, and many struggle to access treatment.
UCSF scientists have found that some cancers, like brain cancer, make unique, jumbled proteins that make them stand out. These newly recognized cancer-specific proteins, or antigens, could speed the development of potent immunotherapies that recognize and attack hard-to-treat tumors.
UCSF scientists discover how cancer cells hijack the protein factory of the cell to churn out MYC protein, the driver of 70% of all cancers.
Scientists used implanted fat cells to gobble up available nutrients around cancer tumors, starving the tumors to death.
Rates of advanced prostate cancer in California rose significantly in the decade since doctors stopped routinely screening all men. A UCSF study reinforces the need for screening that can identify potentially fatal tumors without raising false alarms about ones that pose little threat.
Several cases of the bird flu in humans have been reported in California's Central Valley in 2024. This Q&A explores how the virus spreads, how to prevent infection and whether this is something to be we need to actively protect against.
A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the health risks.
During COVID-19, researchers found that low-dose buprenorphine initiation for fentanyl users was largely unsuccessful, with repeated attempts also failing.
High percentages of children under thirteen years old use social media apps that are meant for ages thirteen and over. Experts suggest parents model healthy behaviors to avoid health risks in children.
A new study paints one of the most detailed pictures of human brain development to date, opening the door to new tests and therapies, including for brain disorders such as autism.
An extended course of Paxlovid appears to help some patients with long COVID, according to a study by UCSF researchers that suggests this treatment option holds promise for some of those struggling with lasting symptoms.
The trending risks you may not know about.
Learn from an expert on how marketing shapes the use of flavored vapes, and and what it means for kids and teens.
Excessive drinking can damage the liver. Yet, unlike obesity or high cholesterol, clinicians only screen for alcohol use by asking their patients how much they drink. Turns out that method is not